Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination

Patients undergoing chronic hemodialysis were among the first to receive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations because of their increased risk for severe coronavirus disease and high case-fatality rates. By using a previously reported cohort from Germany of at-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulovic, Alex, Strengert, Monika, Ramos, Gema Morillas, Becker, Matthias, Griesbaum, Johanna, Junker, Daniel, Lürken, Karsten, Beigel, Andrea, Wrenger, Eike, Lonnemann, Gerhard, Cossmann, Anne, Stankov, Metodi V., Dopfer-Jablonka, Alexandra, Kaiser, Philipp D., Traenkle, Bjoern, Rothbauer, Ulrich, Krause, Gérard, Schneiderhan-Marra, Nicole, Behrens, Georg M.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962909/
https://www.ncbi.nlm.nih.gov/pubmed/35203113
http://dx.doi.org/10.3201/eid2804.211907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962909/
https://www.ncbi.nlm.nih.gov/pubmed/35203113
http://dx.doi.org/10.3201/eid2804.211907

Ejemplares similares